Abstract
A 65-year-old man suffering from acute pancreatitis underwent MRI scanning, which revealed a low signal on the T1 and T2 sequences, and hypovascularity in arterial phase in the head of the pancreas. This corresponded to the area showing the absence of the lower common bile duct. FDG-PET was highly suggestive of pancreatic cancer (T4N1M0, Stage IVa) with lymph node metastasis. He was treated with systemic chemotherapy using gemcitabine (GEM) followed by radiotherapy. His symptoms gradually improved with a reduction in size of the primary lesion. The patient has been receiving systemic chemotherapy using S-1 without recurrence.
MeSH terms
-
Aged
-
Antimetabolites, Antineoplastic / therapeutic use*
-
Combined Modality Therapy
-
Deoxycytidine / analogs & derivatives*
-
Deoxycytidine / therapeutic use
-
Drug Combinations
-
Gemcitabine
-
Humans
-
Magnetic Resonance Imaging
-
Male
-
Neoplasm Staging
-
Oxonic Acid / therapeutic use
-
Pancreatic Neoplasms / diagnostic imaging
-
Pancreatic Neoplasms / drug therapy*
-
Pancreatic Neoplasms / pathology
-
Pancreatic Neoplasms / radiotherapy
-
Remission Induction
-
Tegafur / therapeutic use
-
Tomography, X-Ray Computed
Substances
-
Antimetabolites, Antineoplastic
-
Drug Combinations
-
Deoxycytidine
-
S 1 (combination)
-
Tegafur
-
Oxonic Acid
-
Gemcitabine